IP Library Granted Patent US 7,244,598
Granted Patent B2
US 7,244,598 · App. 09/928,367 · Granted Jul 17, 2007

Biomolecule arrays

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,244,598
App. No.
09/928,367
Granted
Jul 17, 2007
Kind
B2
Abstract

Array systems that facilitate the simultaneous monitoring of many interactions between biological molecules and the analysis of cellular protein interactions with high throughput. The present invention provides methods and arrays for analyzing biochemical pathways by forming an array of immobilized biomolecules; exposing the array to biomolecules in solution; and detecting modification of the immobilized biomolecules, modification of the biomolecules in solution, and/or binding of biomolecules in solution to immobilized biomolecules.

Claims (11)

1. A method for detecting modification of MEK proteins or MAPK proteins of a Raf/MEK/MAPK pathway, comprising the steps of:

a) placing a polymer gel contact mask having holes on a substrate, the holes together with the portions of the substrate which overlie the holes forming cavities;

b) immobilizing inactive MEK proteins and inactive MAPK proteins on areas of the substrate underlying the holes of the polymer gel contact mask that have the size and orientation of wells of a 96 well, 384 well, 1536 well, or 3456 well microwell plate;

c) exposing the inactive MEK proteins and inactive MAPK proteins to a solution of active Raf proteins, active MEK proteins, ATP, and potential inhibitors of at least one of the active Raf proteins or the active MEK proteins;

d) allowing binding of the active Raf proteins and the active MEK proteins to the inactive MEK proteins and the inactive MAPK proteins; and

e) detecting modification of the inactive MEK proteins or the inactive MAPK proteins of the Raf/MEK/MAPK pathway.

2. The method of claim 1 , wherein detecting modification comprises the additional step of quantifying the amount present of the inactive MEK or inactive MAPK proteins of the Raf/MEK/MAPK pathway based on the modification thereof.

3. The method of claim 1 , wherein detecting modification comprises the additional step of qualitatively or quantitatively determining the level of activity of the inactive MEK or inactive MAPK proteins of the Raf/MEK/MAPK pathway based on the modification thereof.

4. The method of claim 1 , wherein detecting the modification comprises the additional step of identifying the affinity or avidity of the inactive MEK or inactive MAPK proteins of the Raf/MEK/MAPK pathway based on the modification thereof.

5. The method of claim 1 , further comprising removing the polymer gel contact mask from the substrate before exposing the inactive MEK proteins and inactive MAPK proteins to the solution of active Raf proteins, active MEK proteins, ATP, and potential inhibitors of at least one of the active Raf proteins or the active MEK proteins.

6. The method of claim 1 , wherein immobilizing the inactive MEK proteins and inactive MAPK proteins on areas of the substrate comprises forming a self-assembled monolayer on the substrate and binding the inactive MEK proteins and inactive MAPK proteins to the self-assembled monolayer.

Assignments (1)
ENTITY CONVERSION Recorded Sep 17, 2025
From: SURFACE LOGIX, INC.
To: SURFACE LOGIX LLC
Reel/Frame 072915/0828 →